Cargando…
miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy
MicroRNAs (miRNAs), a class of small non-coding RNAs, mediate gene expression by either cleaving target mRNAs or inhibiting their translation. They have key roles in the tumorigenesis of several cancers, including non-small cell lung cancer (NSCLC). The aim of this study was to investigate the clini...
Autores principales: | Wang, Fang, Lou, Jian-fang, Cao, Yan, Shi, Xin-hui, Wang, Peng, Xu, Jian, Xie, Er-fu, Xu, Ting, Sun, Rui-hong, Rao, Jian-yu, Huang, Pu-wen, Pan, Shi-yang, Wang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454993/ https://www.ncbi.nlm.nih.gov/pubmed/25952770 http://dx.doi.org/10.1038/emm.2015.17 |
Ejemplares similares
-
miR-638 Serves as a Biomarker of 5-Fluorouracil Sensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Wang, Bin, et al.
Publicado: (2022) -
Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients
por: Li, Minghong, et al.
Publicado: (2018) -
Downregulation of circulating exosomal miR-638 predicts poor prognosis in colon cancer patients
por: Yan, Shushan, et al.
Publicado: (2017) -
CREB1/Lin28/miR-638/VASP Interactive Network Drives the Development of Breast Cancer
por: Hu, Peng-Chao, et al.
Publicado: (2019) -
Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF
por: Cheng, Jiwen, et al.
Publicado: (2016)